David O.

David O. currently serves as the Director of Medical Communications at Karyopharm Therapeutics Inc., having advanced through roles including Associate Director and Senior Manager in the same department since July 2022. Prior to this, David held the position of Senior Manager in Medical Communications at Epizyme until its acquisition by Ipsen. Experience also includes roles as Manager of Medical Affairs at Beth Israel Deaconess Hospital - Milton and Clinical Pharmacist positions at various healthcare organizations. David completed a Doctor of Pharmacy (Pharm.D.) and a Bachelor of Science in Pharmacy Studies at Western New England College of Pharmacy and Health Sciences. David's postgraduate training included a postdoctoral fellowship in Oncology Medical Affairs at TESARO, which was later acquired by GSK. Additionally, David contributed as Adjunct Pharmacy Practice Faculty at Northeastern University.